ClinicalTrials.gg
Sign In

Carcinoma, Ovarian Epithelial clinical trials

The registry lists 798 studies for Carcinoma, Ovarian Epithelial across more than 10 countries. 102 are recruiting or about to start. 365 of them are mainly about Carcinoma, Ovarian Epithelial (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 1,684 studies for Carcinoma, Ovarian Epithelial. How that becomes 796 here

This page counts the studies the registry files under Carcinoma, Ovarian Epithelial, and those it files under no condition that list Carcinoma, Ovarian Epithelialthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,684Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −23List Carcinoma, Ovarian Epithelial as a condition, but the registry did not file them under itMost often written as “Ovarian Epithelial Cancer Recurrent” (6), “Advanced Epithelial Ovarian Cancer” (3), and “Platinum-Resistant Epithelial Ovarian Cancer” (2). The registry filed them under other conditions only, most often Ovarian Neoplasms (14) and Fallopian Tube Neoplasms (8).
  3. −865Match it another way203 name it in the title, 8 in a keyword, and 654 by a synonym or other text the search reads.
  4. 796The count on this page11 of them list Carcinoma, Ovarian Epithelial in their own words; the registry filed them under no condition.

Get an email when these change. Save the Carcinoma, Ovarian Epithelial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
432
Terminated
114
Status unknown
84
Recruiting
75
Active, not recruiting
35
Withdrawn
28

Phase

Phase 2
337
Phase 1
251
Phase 3
100
Early Phase 1
8
Phase 4
4

Where

United States
500
Canada
79
China
71
United Kingdom
66
Italy
47
France
46

Who runs them

National Cancer Institute (NCI) (63) · Gynecologic Oncology Group (42) · Memorial Sloan Kettering Cancer Center (25) · Fred Hutchinson Cancer Center (21) · Lei Li (13) · City of Hope Medical Center (12) · Masonic Cancer Center, University of Minnesota (11) · M.D. Anderson Cancer Center (10)

What is being tested here

Drugs under test in Carcinoma, Ovarian Epithelial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Carboplatin31574
Torvutatug samrotecan333
Paclitaxel21971
Iparomlimab/Tuvonralimab202
Cisplatin1532
Bevacizumab1117
Cyclophosphamide1114
Albumin-Bound Paclitaxel116
Mirvetuximab soravtansine146
Pembrolizumab115

Drug classes tested here Immune checkpoint inhibitors 5 open · Antibody-drug conjugates (ADCs) 3 open · Antimitotic agents 2 open · Tyrosine kinase inhibitors (TKIs) 2 open · PARP inhibitors 2 open

Coming up

25phase 3 studies under way
34studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 75 Carcinoma, Ovarian Epithelial studies recruiting now, 50 (67%) set no upper age limit and 12 (16%) stop at 75 or younger. 2 (3%) take children under 18. 58 (77%) are for women only and 0 (0%) for men only; 4 (5%) take healthy volunteers.

Recruiting studies that take each age, of 75
AgeWomenMen
102 (3%)0 (0%)
1870 (93%)16 (21%)
3075 (100%)17 (23%)
4075 (100%)17 (23%)
5075 (100%)17 (23%)
6575 (100%)17 (23%)
7573 (97%)17 (23%)
8554 (72%)14 (19%)

Across all 798 studies, recruiting or not: 11% stop at 75 or younger and 3% at 65; 13% take children; 72% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Carcinoma, Ovarian Epithelial studies take

Of 55 phase 1 interventional studies under Carcinoma, Ovarian Epithelial, half reached primary completion within 44 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 144 mo34–81 · 55 studies—39 mo32–54 · 29 studies
Phase 1/260 mo37–74 · 26 studies——
Phase 272 mo45–92 · 51 studies——
Phase 355 mo38–110 · 33 studies——
Interventional, no phase66 mo43–93 · 30 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting2

Stopped3

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 798. Browse all 798 → or search them.